Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 25 results found. Search for [ U.S. National Institutes of Health ]

Results 1 to 21 of 25
Associated Press
November 30, 2020
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


Reuters
October 6, 2020
Trump has repeatedly flouted social-distancing guidelines meant to curb the virus' spread and ignored his own medical advisers


Associated Press
September 2, 2020
That cooperative effort, linked with the WHO, would allow nations to take advantage of a portfolio of potential vaccines to ensure their citizens are quickly covered by whichever ones are deemed effective


Reuters
September 1, 2020
The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for COVID-19


Reuters
August 25, 2020
Soumya Swaminathan, WHO chief scientist, said only a few clinical trials of convalescent plasma have produced results, and the evidence, at least so far, has not been convincing enough to endorse it beyond use as an experimental therapy


Reuters
July 28, 2020
Both vaccine candidates rely on a new technology that allows for faster development and manufacturing than traditional vaccine production methods but does not have an extensive track record


Reuters
July 27, 2020
In April, Moderna had received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


Associated Press
July 15, 2020
Tokyo's Nikkei 225 advanced 1.4% to 22,912.24, while the Kospi in South Korea added 0.6% to 2,196.47. In Australia, the S&P/ASX 200 added 1.4% to 6,025.50


Reuters
June 9, 2020
Brazil is now one of the hotspots of the pandemic, with the second highest number of confirmed cases, behind only the United States, and a death toll that last week surpassed Italy's


BusinessToday.In
May 24, 2020
Coronavirus vaccine update: Experts have welcomed the findings, saying the results showed patients on remdesivir cut their recovery time by 27 per cent


Associated Press
May 22, 2020
About a dozen different experimental vaccines are in early stages of human testing or poised to start, mostly in China, the U.S. and Europe, with dozens more in earlier stages of development


Associated Press
May 19, 2020
The Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings, due to sometimes fatal side effects


Chitranjan Kumar
New Delhi, May 18, 2020
Shares of Moderna soared 39 per cent in premarket trading after the biotech announced positive interim data from a phase 1 clinical study of its experimental COVID-19 vaccine


Reuters
May 16, 2020
Interest in Gilead's drug has been high given some promising early data and the lack of approved treatments or preventive vaccines for COVID-19, the disease caused by the novel coronavirus


Reuters
April 30, 2020
U.S. Food and Drug Administration said it has been in discussions with Gilead about making remdesivir available to patients as quickly as possible, but the agency declined to comment on any plans to grant the drug regulatory approval


Reuters
April 25, 2020
There are currently no approved treatments or vaccines for COVID-19, that has killed over 190,000 people globally


PAGES 1 OF 2  12